• Home
  • Search Results

Search Results

2523 studies match your search
Not currently enrolling

Brain research on decision-making

We want to learn how personality traits relate to how adolescents and young adults who are shy or whose emotions and moods change quickly make decisions. We hope this research will help us better understand decision-making and mental health during the transition from adolescence to adulthood.

Age & Gender
  • 18 years ~ 25 years
  • Male, Gender Inclusive
Study Interest
  • Behavior
  • Brain, Head, Nervous System
  • Developmental
  • Mental and Emotional Health
Open

Prenatal Care Support Study for Stress Management, Health Equity, and Preterm Birth Prevention

Are you currently pregnant and at high risk for early delivery or high blood pressure? We're studying whether a personalized prenatal care program with extra support can help reduce stress and improve outcomes for you and your baby-without extra clinic visits. Compensation included.

Age & Gender
  • 18 years ~ 55 years
  • Female
Study Interest
  • Mental and Emotional Health
  • Pregnancy
  • Wellness and Lifestyle
  • and 3 more
Open

Testing the Addition of Anti-Cancer Drug, Cetuximab to Standard of Care Treatment

Do you have incurable, metastatic, or recurrent head and neck squamous cell carcinoma? If so, you may be able to participate in a study to evaluate the addition of the anti-cancer drug, Cetuximab, to standard of care treatment.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Head and Neck)
Open

Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy with Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)

Have you been diagnosed with early-stage breast cancer or ductal carcinoma in situ (DCIS) and have undergone breast conserving surgery (lumpectomy). If so this may be the research for you!! You may be able to take part in a research study to evaluate the effects of the tumor bed boost when given at the same time (called a simultaneous integrated boost, SIB) with the WBI, as opposed to after the WBI.

Age & Gender
  • 50 years ~ 99 years
  • Female
Study Interest
  • Cancer (Breast)
  • Women's Health

Comparison of drug combinations to prevent graft-versus-host disease after stem cell transplant

The purpose of this study to see if the drug ruxolitinib with the drugs tacrolimus and methotrexate given before and following a peripheral blood stem cell transplant will prevent graft-versus-host disease (GVHD), a serious complication of a stem cell transplant, better than the drugs post-transplant cyclophosphamide, tacrolimus, and mycophenolate mofetil.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia, Lymphoma)
  • Transplant
Open

Understanding Sickle Cell Trait

Do you have sickle cell trait or wonder if you might? Join our study to learn more about how having sickle cell trait could impact your health. The study uses simple lab tests, and participants receive compensation.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Blood Conditions
  • Healthy Volunteer or General Population
  • Minority Health
Not currently enrolling

Women's Health in Midlife (WHIM)

The purpose of this research is to evaluate the various mood symptoms linked to Perimenopausal Depression (PMD) among a diverse group of women in the menopause transition.

Age & Gender
  • 40 years ~ 60 years
  • Female
Study Interest
  • Mental and Emotional Health
  • Minority Health
  • Sexual and/or Reproductive Health
  • Women's Health
Visit Location
100% Remote (online, phone, text)
Not currently enrolling

Athletic trainers and concussion risk reduction strategies

To determine how Athletic Trainers' perceive the effectiveness of concussion risk reduction strategies and how their experiences vary in dealing with concussion risk reduction strategies.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Opinions and Perceptions
Visit Location
100% Remote (online, phone, text)
Open

Study of MRTX1719 in Patients with Advanced Cancer and a Specific Genetic Change

If you have a solid tumor that has not responded to other treatments and have no remaining therapy options, you may be eligible for the trial. Participants will receive the study drug at no cost.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lung, Pancreatic, Phase 1 Trials (all cancers))
Not currently enrolling

Study of LY3537982 and Immunotherapy with or Without Chemotherapy for People with Non-Small Cell Lung Cancer

The purpose of this study is to see if adding LY3537982 to standard cancer treatments works better than just using the standard treatments alone for people with advanced non-small cell lung cancer (NSCLC) who have not yet been treated.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Lung)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research